Fifth Framework Programme
Quality of Life Programme - Key Action 2: Control of infectious
diseases
European Union-backed research projects focusing
on the socio-economic aspects of the life sciences and biotechnologies
sectors are presented below. These projects, listed with their
title and contract number, were carried out during the Fifth
Framework Programme (1998-2002) under Quality
of life programme, and relate to the control of infectious
diseases.
Development
of strategies for control and prevention of antibiotic resistance
in European Hospitals - QLK2-CT-2001-00915
Creutzfeldt-Jacob
disease: epidemiology, risk factors, diagnostic tests and
genetics - QLK2-CT-2001-02248
Human
Transmissible Spongiform Encephalopathies: The Neuropathology
network - QLK2-CT-2000-00837
New
generation genetic markers and techniques for the epidemiology
and control of tuberculosis - QLK2-CT-2000-00630
Sea-Lice
Resistance to Chemotherapeutants diagnosis, mechanisms, dynamics
and control - QLK2-CT-2000-00809
Paediatric
European Network For Treatment AIDS - QLK2-CT-2000-00150
Human
Pneumocystis carinii infection in immunocompetent hosts: a
public health issue in Europe - QLK2-CT-2000-01369
Concerted
Action on SeroConversion to AIDS and Death in Europe -
QLK2-CT-2000-01431
European
Collaborative Study on Pregnant HIV-Infected Women and their
children - QLK2-CT-2000-00002
Establishment
of novel targets for risk assessment and monitoring of xenogeneic
infections in the course of animal to human transplantation
- QLK2-CT-1999-40210
Improving
Vaccination in Early Life (Neovac) - QLK2-CT-1999-00429
Development
of an efficacious vaccine against animal brucellosis that
is harmless for humans - QLK2-CT-1999-00014
A
cluster for tuberculosis vaccine development - QLK2-CT-1999-01093
Generic
coronavirus vaccine vectors for protection of farm animals
against mucosal infection - QLK2-CT-1999-00002
A
European malaria vaccine development consortium: EUROMALVAC
1 - QLK2-CT-1999-01293
European
(EURO) network for development of novel safe vaccines based
on new generation Amplicons (AMP) and other Defective HSV-1
derived vectors as foreign antigen delivery systems -
QLK2-CT-1999-00055
Mucosal
immunisation - Cluster project - QLK2-CT-1999-00228
Development
of therapeutic vaccines for chronic infections caused by the
hepatitis c virus - QLK2-CT-1999-00588
European
network for vaccine evaluation in primates: combined vector
immunisations for AIDS vaccine development - QLK2-CT-1999-00871
Bivalent
hantavirus vaccine for Europe: Different approaches and evaluation
in animal models - QLK2-CT-1999-01119
SIV/HIV
vaccines: Detecting efficacy and explaining inefficacy
- QLK2-CT-1999-01215
European
vaccine effort against HIV/AIDS - QLK2-CT-1999-01321<
|
